載入...
Inhibition of Histone Methyltransferase, Histone Deacetylase, and β-Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells
Previously, we reported that treatment with the G9a histone methyltransferase inhibitor BIX01294 causes bone marrow mesenchymal stem cells (MSCs) to exhibit a cardiocompetent phenotype, as indicated by the induction of the precardiac markers Mesp1 and brachyury. Here, we report that combining the hi...
Na minha lista:
| 發表在: | Stem Cells Int |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5534312/ https://ncbi.nlm.nih.gov/pubmed/28791052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3464953 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|